company background image
CIPLA logo

Cipla NSEI:CIPLA Stock Report

Last Price

₹1.49k

Market Cap

₹1.2t

7D

-1.0%

1Y

71.7%

Updated

18 Mar, 2024

Data

Company Financials +

CIPLA Stock Overview

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally.

CIPLA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends5/6

Rewards

Risk Analysis

No risks detected for CIPLA from our risk checks.

Cipla Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cipla
Historical stock prices
Current Share Price₹1,488.45
52 Week High₹1,519.00
52 Week Low₹852.00
Beta0.37
1 Month Change3.31%
3 Month Change20.32%
1 Year Change71.74%
3 Year Change92.59%
5 Year Change182.52%
Change since IPO46,025.84%

Recent News & Updates

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Feb 14
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Jan 26
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Recent updates

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Feb 14
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Jan 26
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Jan 08
Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Nov 15
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Oct 05
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Aug 04
Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Is Cipla (NSE:CIPLA) A Risky Investment?

Mar 24
Is Cipla (NSE:CIPLA) A Risky Investment?

A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Mar 06
A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Dec 11
Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Aug 19
Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Jul 30
Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Cipla (NSE:CIPLA) Could Easily Take On More Debt

Jul 14
Cipla (NSE:CIPLA) Could Easily Take On More Debt

If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Jul 01
If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 30
Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Mar 23
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Dec 18
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Calculating The Fair Value Of Cipla Limited (NSE:CIPLA)

Dec 05
Calculating The Fair Value Of Cipla Limited (NSE:CIPLA)

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Oct 27
Is Cipla (NSE:CIPLA) Using Too Much Debt?

If You Like EPS Growth Then Check Out Cipla (NSE:CIPLA) Before It's Too Late

Sep 16
If You Like EPS Growth Then Check Out Cipla (NSE:CIPLA) Before It's Too Late

Cipla Limited (NSE:CIPLA) Shares Could Be 23% Above Their Intrinsic Value Estimate

Aug 31
Cipla Limited (NSE:CIPLA) Shares Could Be 23% Above Their Intrinsic Value Estimate

It's Unlikely That Cipla Limited's (NSE:CIPLA) CEO Will See A Huge Pay Rise This Year

Aug 18
It's Unlikely That Cipla Limited's (NSE:CIPLA) CEO Will See A Huge Pay Rise This Year

Cipla (NSE:CIPLA) Could Easily Take On More Debt

Jul 12
Cipla (NSE:CIPLA) Could Easily Take On More Debt

Are Cipla Limited (NSE:CIPLA) Investors Paying Above The Intrinsic Value?

May 28
Are Cipla Limited (NSE:CIPLA) Investors Paying Above The Intrinsic Value?

Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Mar 21
Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Here's Why I Think Cipla (NSE:CIPLA) Is An Interesting Stock

Mar 08
Here's Why I Think Cipla (NSE:CIPLA) Is An Interesting Stock

Do Fundamentals Have Any Role To Play In Driving Cipla Limited's (NSE:CIPLA) Stock Up Recently?

Feb 23
Do Fundamentals Have Any Role To Play In Driving Cipla Limited's (NSE:CIPLA) Stock Up Recently?

Have Insiders Sold Cipla Limited (NSE:CIPLA) Shares Recently?

Feb 11
Have Insiders Sold Cipla Limited (NSE:CIPLA) Shares Recently?

Shareholder Returns

CIPLAIN PharmaceuticalsIN Market
7D-1.0%-2.6%-3.7%
1Y71.7%65.3%44.0%

Return vs Industry: CIPLA exceeded the Indian Pharmaceuticals industry which returned 65.3% over the past year.

Return vs Market: CIPLA exceeded the Indian Market which returned 44% over the past year.

Price Volatility

Is CIPLA's price volatile compared to industry and market?
CIPLA volatility
CIPLA Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.7%
10% most volatile stocks in IN Market10.2%
10% least volatile stocks in IN Market4.0%

Stable Share Price: CIPLA has not had significant price volatility in the past 3 months.

Volatility Over Time: CIPLA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
193532,323Umang Vohrahttps://www.cipla.com

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women’s health, ophthalmology, and neuro psychiatry.

Cipla Limited Fundamentals Summary

How do Cipla's earnings and revenue compare to its market cap?
CIPLA fundamental statistics
Market cap₹1.20t
Earnings (TTM)₹37.08b
Revenue (TTM)₹251.16b

32.4x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CIPLA income statement (TTM)
Revenue₹251.16b
Cost of Revenue₹90.36b
Gross Profit₹160.81b
Other Expenses₹123.72b
Earnings₹37.08b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)45.93
Gross Margin64.02%
Net Profit Margin14.76%
Debt/Equity Ratio3.8%

How did CIPLA perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

24%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.